--- title: "NANTIAN Information released its performance for the first three quarters, with a net loss attributable to the parent company of 10.8998 million yuan" type: "News" locale: "en" url: "https://longbridge.com/en/news/261862590.md" description: "According to the Zhitong Finance APP, NANTIAN released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 7.091 billion yuan, a year-on-year increase of 21.90%. The net loss attributable to shareholders of the listed company was 10.8998 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 20.6436 million yuan. The basic loss per share was 0.0277 yuan" datetime: "2025-10-20T10:58:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/261862590.md) - [en](https://longbridge.com/en/news/261862590.md) - [zh-HK](https://longbridge.com/zh-HK/news/261862590.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/261862590.md) | [繁體中文](https://longbridge.com/zh-HK/news/261862590.md) # NANTIAN Information released its performance for the first three quarters, with a net loss attributable to the parent company of 10.8998 million yuan According to the Zhitong Finance APP, NANTIAN (000948.SZ) released its third-quarter report for 2025, showing that the company's operating revenue for the first three quarters was 7.091 billion yuan, a year-on-year increase of 21.90%. The net loss attributable to shareholders of the listed company was 10.8998 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 20.6436 million yuan. The basic loss per share was 0.0277 yuan ### Related Stocks - [NANTIAN (000948.CN)](https://longbridge.com/en/quote/000948.CN.md) ## Related News & Research - [08:19 ETTata Communications Maintains a Leader Position for 13th Straight Year in Gartner® Magic Quadrant™](https://longbridge.com/en/news/281522709.md) - [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/en/news/281325910.md) - [CBOT Trends-Wheat down 10-12 cents, corn down 4-6 cents, soy down 7-9 cents](https://longbridge.com/en/news/281375178.md) - [GRAINS-Corn rises for 2nd session on outlook for lower U.S. planting](https://longbridge.com/en/news/281270135.md) - [11:33 ETFitness, Health and Wellness Experts Team Up to 'Get Fit for No Kid Hungry' with New On-Demand Initiative](https://longbridge.com/en/news/281213207.md)